| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | Director | Apr 01, 2024 | Option Exercise | $5.12 | 14,052 | 71,946 | 131,658 | Apr 02, 2024, 04:59 PM | |
| SGEN | Seagen Inc. | Simonian Nancy A | Director | Dec 14, 2023 | Option Exercise | $229.00 | 62,753 | 14,370,437 | 0 | Dec 15, 2023, 06:46 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Nov 01, 2023 | Option Exercise | $2.22 | 13,401 | 29,750 | 100,144 | Nov 02, 2023, 04:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Apr 03, 2023 | Option Exercise | $2.58 | 1,852 | 4,778 | 73,420 | Apr 04, 2023, 06:54 PM | |
| SGEN | Seagen Inc. | Simonian Nancy A | Director | Dec 12, 2022 | Option Exercise | $36.70 | 8,750 | 321,125 | 62,753 | Dec 14, 2022, 05:49 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Apr 01, 2022 | Option Exercise | $1.12 | 58,883 | 65,949 | 692,723 | Apr 04, 2022, 05:02 PM | |
| SGEN | Seagen Inc. | Simonian Nancy A | Director | Mar 02, 2022 | Option Exercise | $20.04 | 25,000 | 501,000 | 52,500 | Mar 04, 2022, 05:09 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Dec 18, 2020 | Option Exercise | $6.81 | 29,917 | 203,612 | 563,606 | Dec 21, 2020, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Dec 23, 2019 | Option Exercise | $3.04 | 52,401 | 159,299 | 533,689 | Dec 23, 2019, 04:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Nov 29, 2018 | Option Exercise | $1.23 | 110,588 | 136,224 | 481,288 | Dec 03, 2018, 04:06 PM |
Menu